DC Investments Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,020
Closed -$217K 58
2021
Q3
$217K Buy
+1,020
New +$235K 0.4% 48
2020
Q3
Sell
-3,130
Closed -$738K 88
2020
Q2
$738K Buy
3,130
+1,038
+50% +$237K 0.27% 42
2020
Q1
$424K Buy
2,092
+228
+12% +$49.8K 0.34% 105
2019
Q4
$449K Sell
1,864
-907
-33% -$200K 0.34% 145
2019
Q3
$536K Sell
2,771
-102
-4% -$19.6K 0.31% 111
2019
Q2
$529K Buy
2,873
+1,209
+73% +$216K 0.3% 140
2019
Q1
$316K Hold
1,664
0.2% 211
2018
Q4
$324K Buy
+1,664
New +$325K 0.26% 188
2018
Q2
Sell
-12,362
Closed -$2.11M 290
2018
Q1
$2.11M Buy
12,362
+8,544
+224% +$1.57M 1.41% 4
2017
Q4
$664K Buy
+3,818
New +$676K 0.27% 97

Other funds holding AMGN

DC Investments Management's AMGN Position: Q4 2021 in Review

DC Investments Management sold out of Amgen (AMGN) in Q4 2021, closing a stake of 1,020 shares — an estimated $217K sold.

DC Investments Management first reported a position in AMGN in Q4 2017 and held it in 10 quarters. The position peaked at $2.11M in Q1 2018. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • DC Investments Management reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • DC Investments Management sold 1,020 Amgen shares in Q4 2021, an estimated $217K.
  • DC Investments Management first reported a position in Amgen in Q4 2017 and held it in 10 quarters.
  • DC Investments Management's Amgen position peaked at $2.11M in Q1 2018.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on DC Investments Management's 13F filing for Q4 2021, filed 11 Feb 2022.